- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Sichuan Cancer Hospital & Institute
I alt 3903 resultater
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterendeGastrointestinal kræftKina
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Shandong Cancer Hospital and InstituteAfsluttetIkke-småcellet lungekræftKina
-
Peking University Cancer Hospital & InstituteUkendtAvanceret ikke-pladeepitel, ikke-småcellet lungekræftKina
-
Peking University Cancer Hospital & InstituteUkendtKræft i bugspytkirtlen | Gastrisk Adenocarcinom | Cholangiocarcinom | HER2-negativ brystkræftKina
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteUkendtQOL; Livskvalitet;mavekræft; Gastrectomi; Neoadjuverende kemoterapiKina
-
Peking University Cancer Hospital & InstituteUkendtLymfom | Positron-emissionstomografi | Tumor, fastKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtAvanceret slimhinde melanomKina
-
Shandong Cancer Hospital and InstituteAfsluttetEsophageale neoplasmerKina
-
Shandong Cancer Hospital and InstituteAfsluttetEsophageale neoplasmerKina
-
Peking University Cancer Hospital & InstituteUkendtKarcinom, ikke-småcellet lunge | Docetaxel | NivolumabKina
-
Shandong Cancer Hospital and InstituteUkendtBrystneoplasmer | Dermatitis | Forebyggelse og kontrol | Epigallocatechin Gallate
-
Peking University Cancer Hospital & InstituteUkendtTilbagevendende småcellet lungekræftKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtAvanceret melanomKina
-
Peking University Cancer Hospital & InstituteUkendtHepatocellulært karcinomKina
-
Peking University Cancer Hospital & InstituteUkendtMetastatisk nyrecellekarcinomKina
-
Shandong Cancer Hospital and InstituteUkendtMetastatisk brystkræft
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma MetastaseKina
-
Peking University Cancer Hospital & InstituteUkendtEverolimus hos udvalgte patienter med metastatisk melanom: undersøgelse af effektivitet og sikkerhedMelanom | Neoplasma Metastase | TOR serin-threoninkinaserKina
-
Shandong Cancer Hospital and InstituteUkendtCarcinom, hepatocellulært | PHENYTOIN/SORAFENIB [VA lægemiddelinteraktion]Kina
-
Peking University Cancer Hospital & InstituteRekrutteringÆggelederkarcinom | Ovariekarcinom | Primært peritonealt karcinomKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Shandong Cancer Hospital and InstituteRekrutteringIntrahepatisk cholangiocarcinomKina
-
Shandong Cancer Hospital and InstituteRekrutteringKolorektal cancer | Strålebehandling | Immunterapi | Målrettet terapiKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuMavekræft | Spiserørskræft | Risikostratificering | Præcisionsscreening | Sekventiel screeningKina
-
Shandong Cancer Hospital and InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuIndsamling af kanalkarcinomKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuHER2-positiv tyktarmskræft | HER2-positiv galdevejskræftKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringLevermetastaser tyktarmskræft | Avanceret kolorektalt karcinomKina
-
Peking University Cancer Hospital & InstituteRekrutteringIkke småcellet lungekræftKina
-
Shandong Cancer Hospital and InstituteRekrutteringAvanceret esophageal pladecellekræftKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Shandong Cancer Hospital and InstituteIkke rekrutterer endnuBrystkræft kvinde | Patientrapporteret resultat | Brystbevarende kirurgi | Onkologisk sikkerhed
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuHCC | Regorafenib | Transarteriel kemoembolisering | Hepatisk arteriel infusion Kemoterapi
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuIkke småcellet lungekræftKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuSlimhinde melanom | Neoadjuverende behandlingKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Shandong Cancer Hospital and InstituteIkke rekrutterer endnuSmåcellet lungekræft i omfattende stadie
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering